1. Quality of life in a large multinational haemophilia B cohort (The B-Natural study) – Unmet needs remain
- Author
-
Erik Berntorp, Petra LeBeau, Margaret V. Ragni, Munira Borhany, Yasmina L. Abajas, Michael D. Tarantino, Katharina Holstein, Stacy E. Croteau, Raina Liesner, Cristina Tarango, Manuela Carvalho, Catherine McGuinn, Eva Funding, Christine L. Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M. Reiss, Roshni Kulkarni, Michelle Witkop, Stefan Lethagen, Rebecca Krouse, Amy D. Shapiro, and Jan Astermark
- Subjects
QoL ,Adolescent ,Visual Analog Scale ,EQ-5D ,FIX ,Hematology ,General Medicine ,haemophilia B ,Hemophilia B ,Severity of Illness Index ,Cohort Studies ,inhibitor ,Child, Preschool ,Surveys and Questionnaires ,Quality of Life ,Humans ,prophylaxis ,Child ,Genetics (clinical) - Abstract
Introduction: The B-Natural study is a multicentre, multinational, observational study of haemophilia B (HB) designed to increase understanding of clinical manifestations, treatment and quality of life (QoL). Aim: To characterise and compare QoL in HB across disease severity groups and individuals with inhibitors to identify gaps in treatment. Methods: A total of 224 individuals from 107 families were enrolled from a total of 24 centres in North America (n = 16), Europe (n = 7) and Asia (n = 1). Of these, 68 (30.4%) subjects had severe (5–
- Published
- 2022